Nordimed
Nordimed, officially known as Nordimed A/S, is a prominent player in the medical technology industry, headquartered in Denmark (DK). Founded in 2005, the company has established itself as a leader in providing innovative healthcare solutions across Europe and beyond. Specialising in advanced medical devices and diagnostic tools, Nordimed is recognised for its commitment to quality and precision. Their core products, which include state-of-the-art imaging systems and patient monitoring solutions, are designed to enhance clinical outcomes and streamline healthcare processes. With a strong market position, Nordimed has achieved significant milestones, including partnerships with leading healthcare institutions and a growing portfolio of patented technologies. The company continues to drive advancements in medical technology, ensuring that healthcare professionals have access to the best tools available.
DitchCarbon Score
How does Nordimed's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Other Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Nordimed's score of 6 is higher than 63% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Nordimed's reported carbon emissions
NordiMED, headquartered in Denmark, has set ambitious climate commitments despite not having specific carbon emissions data available. The company has committed to maintaining zero Scope 1 emissions through 2030, demonstrating a strong focus on direct emissions reduction. Additionally, NordiMED aims to reduce its absolute Scope 2 greenhouse gas emissions by 42% by 2030, using 2022 as the baseline year. This target has been validated through a streamlined process for small and medium-sized enterprises (SMEs) and aligns with the necessary reductions to limit global warming to 1.5°C. Furthermore, NordiMED is dedicated to measuring and reducing its Scope 3 emissions, which encompass indirect emissions from its value chain. These commitments reflect NordiMED's proactive approach to addressing climate change and contributing to a sustainable future.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Nordimed is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
